Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel, Randomised, Double Blind, Placebo Controlled Study to Investigate the Effect of NOGO on Overactive Bladder in Men and Women

NCT04357223 is registered in ClinicalTrials.gov with SagaNatura as lead sponsor.

NCT NCT04357223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04357223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel, Randomised, Double Blind, Placebo Controlled Study to Investigate the Effect of NOGO on Overactive Bladder in Men and Women
Lead sponsor
SagaNatura
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2020
Completion date
March 1, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nocturia, overactive bladder